Miraculins Executes Final Agreement to Acquire PREVU(TM) Skin Cholesterol Test – MarketWatch (press release)

posted on Aug 05 by in the Uncategorized category

Miraculins Executes Final Agreement to Acquire PREVU(TM) Skin Cholesterol Test
MarketWatch (press release)
The Company's lead program, a suite of biomarkers for preeclampsia, is partnered with Inverness Medical Innovations (NYSE: IMA), one of the world's largest ...

and more »

Leave a Response

Get Adobe Flash playerPlugin by wpburn.com wordpress themes